- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Swissray slaps Elscint with lawsuit
Fraud and breach of contracts headline the lawsuit Swissray International has filed against Elscint in connection with two distribution agreements executed in August 1998. The suit, filed in the New York Supreme Court, alleges that Elscint violated
Fraud and breach of contracts headline the lawsuit Swissray International has filed against Elscint in connection with two distribution agreements executed in August 1998. The suit, filed in the New York Supreme Court, alleges that Elscint violated agreements to distribute Swissray ddR technology internationally and for Swissray to distribute Elscint imaging equipment in Switzerland. The complaint alleges improprieties in Elscint's negotiation tactics, fraudulent concealment of the impending sale of its imaging businesses, and breaches of the distribution agreements following the sale. Swissray turned to the courts because discussions with Elscint failed to resolve these issues, according to Ruedi G. Laupper, Swissray chairman, president, and CEO. Laupper alleges that the distribution agreement with Elscint markedly delayed the deployment of Swissray technology internationally.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
